SPEAKERS
María J. Alcaraz
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Valencia, Spain
Otis Attucks
VTV Therapeutics, High Point, NC, U.S.A.
Antonio Cuadrado
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Sharon P. Cousin
Reata Pharmaceuticals. Irving, Texas, U.S.A.
Albena Dinkova-Kostova
Division of Cancer Research, School of Medicine, University of Dundee, Dundee, Scotland, UK. Departments of Medicine and Pharmacology and Molecular Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, U.S.A.
Steve Franklin
Evgen Pharma plc. Liverpool. U.K.
John D. Hayes
Division of Cancer Research, Jacqui Wood Cancer Centre, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland, UK
Thomas W. Kensler
Johns Hopkins University and University of Pittsburgh, U.S.A.
Anna-Liisa Levonen
A.I. Virtanen Institute for Molecular Sciences, University of Eastern Finland, Kuopio, Finland
Rafael León
Instituto de Investigación Sanitaria, Servicio de Farmacología Clínica, Hospital Universitario de la Princesa, Madrid, Spain
William L. Rumsey
GlaxoSmithKline, King of Prussia, PA, U.S.A.
Harald Schmidt
Department of Pharmacology and Personalized Medicine, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
Michael B. Sporn
Norris Cotton Cancer Center and Department of Molecular and Systems Biology, Dartmouth College, Lebanon, U.S.A.
Ángela M. Valverde
Instituto de Investigaciones Biomédicas “Alberto Sols” CSIC-UAM, IIBm and CIBERdem (ISCIII), Madrid, Spain
Geoffrey Wells
UCL School of Pharmacy, University College London, London, U.K.
PARTICIPANTS
Esther Aix
Reata Pharmaceuticals. Irving, Texas, U.S.A.
Coral Barbas
Center for Metabolomics and Bioanalysis (CEMBIO), Faculty of Pharmacy, San Pablo CEU University, Madrid, Spain
Sergio Cano Peiró
Department of Pharmacology and Therapeutics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Ana I. Casas Guijarro
Department of Pharmacology and Personalized Medicine, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
Sara Castro Sánchez
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Pablo Duarte
Department of Pharmacology and Therapeutics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Maribel Escoll Guerrero
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Martín Estrada Valencia
Instituto de Química Médica (IQM-CSIC), Madrid, Spain
Raquel Fernández Ginés
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Cristina Fernández Medinaceli
Department of Pharmacology and Therapeutics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Luisa Ferrándiz
Instituto Interuniversitario de Investigación de Reconocimiento Molecular y Desarrollo Tecnológico (IDM), Universitat Politècnica de València, Universitat de València, Valencia, Spain
Marcos Galán Ganga
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Ángel J. García Yagüe
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Clara Herrera Arozamena
Instituto de Química Médica (IQM-CSIC), Madrid, Spain
Raymond Houck
Aclipse Therapeutics, U.S.A.
Janusz Kulagowski
Parkinson’s UK, London, UK
Diego Lastra Martínez
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Isabel Lastres Becker
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Manuela G. López
Department of Pharmacology and Therapeutics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
José Lombardía
Department of Pharmacology and Therapeutics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Enrique Luengo Martín
Department of Pharmacology and Therapeutics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Maria Angeles Martinez-Grau
Eli Lilly and Company. Madrid, Spain
Richard J. Mead
University of Sheffield, Sheffield, U.K.
Patrycja Michalska
Department of Pharmacology and Therapeutics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
María Monsalve
Instituto de Investigaciones Biomédicas “Alberto Sols” CSIC-UAM, Madrid, Spain
Joan Montaner
Institute of Biomedicine of Seville (IBIS), Seville, Spain
Shobhana Natarajan
Reata Pharmaceuticals. Irving, Texas, U.S.A.
Cristian Nogales
Department of Pharmacology and Personalized Medicine, Cardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands
Marta Pajares
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
H. Joseph Reiser
Aclipse Therapeutics, U.S.A.
Natalia Robledinos Antón
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Maria I. Rodríguez-Franco
Instituto de Química Médica (IQM-CSIC), Madrid, Spain
Ana I. Rojo
Department of Biochemistry, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Cristina Santa
Reata Pharmaceuticals. Irving, Texas, U.S.A.
Francisco J. Schopfer
Complexa Inc. and Dept. of Pharmacology and Chemical Biology, University of Pittsburgh, PA. USA
Klaus Seedorf
Center for Therapeutic Innovation Metabolism, Servier, Suresnes, France
Svetlana Silverman
Comprehensive Breast Cancer Program, Northern Alberta, Canada
Pamela J. Shaw
University of Sheffield, Sheffield, U.K.
Ning Shan
Aclipse Therapeutics, U.S.A.
Paula Trigo Alonso
Department of Pharmacology and Therapeutics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Lina Trujillo
Department of Pharmacology and Therapeutics, Faculty of Medicine, Autonomous University of Madrid, Madrid, Spain
Carmen Valcarce
VTV Therapeutics, High Point, NC, U.S.A.
Brian T. Wipke
Biogen. Cambridge, MA, U.S.A.